바로가기 메뉴
본문 바로가기
주메뉴 바로가기
강명주

Myoung Joo Kang

Hemato-oncology

Specialty

Solid tumor(Stomach cancer, Colon cancer, Pancreatic cancer, Hepatobiliary cance

Treatment hours

Mon, Tue, Wed, Thur, Fri, Sat
Mon Tue Wed Thu Fri Sat
Education

1998. 3 ~ 2002. 2 M.D.

College of Medicine

Inje University

Busan, Korea

2007. 3 ? 2009. 2 Master of Science

Postgraduate School

Inje University

Busan, Korea

2011.3- 2015.2 Ph.D.

Internal Medicine

College of Medicine

Graduate School of Kosin University

Busan, Korea

2017.4 - Associate professor

Department of Hemato-Oncology

Haeundae Paik Hospital

University of Inje College of Medicine

Busan, Korea

Career

1998. 3 ? 2002. 2 M.D.

College of Medicine

Inje University

Busan, Korea

2007. 3 ? 2009. 2 Master of Science

Postgraduate School

Inje University

Busan, Korea

2011.3- 2015.2 Ph.D.

Internal Medicine

College of Medicine

Graduate School of Kosin University

Busan, Korea

2017.4 - Associate professor

Department of Hemato-Oncology

Haeundae Paik Hospital

University of Inje College of Medicine

Busan, Korea

Main Activities

Clinicl study for solid tumor, palliative treatment, chemotherapy

Research/Publication

2006-2017 SCI, SCIE

1. Kang MJ, Ryoo BY, Ryu MH, Koo DH, Chang HM, Lee JL, Kim TW, Kang YK. Venous thromboembolism (VTE) in patients with advanced gastric cancer: an Asian experience. Eur J Cancer. Mar;48(4):492-500, 2012.

2. Kang MJ, Hong YS, Kim KP, Kim SY, Baek JY, Ryu MH, Lee JL, Chang HM, Kim MJ, Chang HJ, Kang YK, Kim TW. Biweekly cetuximab plus irinotecan as second-line chemotherapy for patients with irinotecan-refractory and KRAS wild-type metastatic colorectal cancer according to epidermal growth factor receptor expression status. Invest New Drugs. Aug;30(4):1607-13, 2012

3. Kang MJ, Lee JL, Kim TW, Lee SS, Ahn S, Park DH, Lee SS, Seo DW, Lee SK, Kim MH. Randomized phase II trial of S-1 and cisplatin versus gemcitabine and cisplatin in patients with advanced biliary tract adenocarcinoma. Acta Oncol. Sep;51(7):860-6, 2012.